ArticlePoultry science2026
Effect of heat stress and GlyNAC supplementation on jejunal morphology, hepatic inflammation infiltration and distribution of GSH content in chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study evaluated the effects of cyclic heat stress (cHS) and diets supplemented with a combination of glycine and N-acetylcysteine (GlyNAC) on growth performance, serum antioxidant capacity and glutathione (GSH) content in serum, liver and pectoral muscles of Cyan-shank partridge chickens. Sixty-four male chickens (60 days old) were selected and randomly divided into four groups: CON + TN (basal diet; TN, thermoneutral condition with continuous 25 °C), GlyNAC + TN (basal diet + GlyNAC; TN), CON + cHS (basal diet; cHS, 32 °C for 4 h daily), and GlyNAC + cHS (basal diet + GlyNAC; cHS). The experimental period was 7 days. Results indicated that cHS significantly increased rectal temperature of chickens during heat treatment period (P < 0.05). Nevertheless, neither cHS nor GlyNAC supplementation affected growth performance or serum malondialdehyde levels. GlyNAC supplementation increased the GSH content in serum, liver and pectoral muscle (P < 0.05), but neither cHS nor GlyNAC altered jejunal GSH levels. The cHS decreased the ratio of villous height to crypt depth (V:C) and increased hepatic inflammatory infiltration score (IIS), while GlyNAC supplementation improved both the V:C ratio and hepatic IIS (P < 0.05). In liver, cHS downregulated the protein expression of caspase 3 and glutamate-cysteine ligase modifier subunit (GCLM), as well as the mRNA expression of GCLM gene. In contrast, GlyNAC supplementation upregulated hepatic caspase 3 protein expression and the mRNA expression of GCLM genes (P < 0.05). In conclusion, dietary GlyNAC supplementation maintained the elevated GSH content in both serum and liver, while alleviating cHS-induced impairment of jejunal integrity and hepatic inflammatory infiltration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.